• Most Popular
  • Most Shared

EU panel makes no changes to Merck's Gardasil label

Thu Jan 24, 2008 11:25am EST

Stocks

   

LONDON, Jan 24 (Reuters) - Europe's drug watchdog on Thursday said it would make no changes to the label of Merck & Co's (MRK.N) cervical cancer treatment Gardasil, saying the benefits outweigh any risks.

Stocks

The European Medicines Agency said it had received reports of the deaths of two women in the European Union who had previously used the vaccine but no link with the drug has been established.

Gardasil is approved in the European Union for the prevention of cervical cancer and other diseases caused by the human papilloma virus. An estimated 1.5 million women have been vaccinated with the drug in Europe, the agency said. (Reporting by Michael Kahn and Marc Jones; Editing by Rory Channing)

Stocks


More from Reuters

Photo

Obama will not rush Afghan troop drawdown

OSLO (Reuters) - There will be no "precipitous drawdown" of U.S. forces in Afghanistan and U.S. troops could still be in the country for years to come, President Barack Obama said on Thursday.

» More Top News
A security personnel stands guard near oil pipelines at Tawke oil field near Dahuk, 400 km (245 miles) north of Baghdad May 9, 2009. REUTERS/Azad Lashkari

Now or never for Big Oil

The pressure's on for oil giants looking to secure rare access to cheap Middle East reserves as Iraq gears up to auction off some of the world's largest untapped oilfields.  Full Article 

Energy
A glass of tap water is served at a restaurant in New York June 10, 2009 REUTERS/Shannon Stapleton

G7 glass half empty

Recovering from a punishing global recession has forced the world's richest nations to pay dearly, prompting subdued growth prospects and delayed sighs of relief.   Full Article 

Global markets